Medicines funding: Value for money is nothing new.
Brougham
Matthew
M
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D009520:New Zealand
Healthc Pap. 2002;3(1):83-5; discussion 87-94
12811116
Pharmacoeconomics. 1999 Dec;16(6):649-60
10724792
BMJ. 2007 Jul 21;335(7611):122-3
17641343
N Z Med J. 2005 Aug 12;118(1220):U1621
16132079